Kristina Burow - Director, 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Kristina Burow - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by Kristina Burow for Neumora Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.2M $146M $11.98 Jun 13, 2024 By ARCH Venture Fund X, L.P.
Common Stock 11.9M $142M $11.98 Jun 13, 2024 By ARCH Venture Fund X Overage, L.P.
Common Stock 4.13M $49.5M $11.98 Jun 13, 2024 By ARCH Venture Fund XII, L.P.
Common Stock 2.32M $27.8M $11.98 Jun 13, 2024 By ARCH Venture Fund VIII Overage, L.P.
Common Stock 1.39M $16.6M $11.98 Jun 13, 2024 By ARCH Venture Fund VII, L.P.
Common Stock 47.7K $572K $11.98 Jun 13, 2024 Direct
Stock Option (Right to Buy) 28.6K Jun 13, 2024 Direct Common Stock

Transactions reported by Kristina Burow for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.